[Retroperitoneal fibrosis due to ergotamine. Apropos a case].
OBJECTIVE
This paper reviews retroperitoneal fibrosis secondary to ergotamine and evaluated the current tools in its diagnosis.


RESULTS
A well documented case of a young patient with retroperitoneal fibrosis resulting from chronic use of ergotic agents is presented. The fibrous plaque remitted after withdrawal of the causal agent.


CONCLUSIONS
The importance of contrast-enhanced CT in the diagnosis of retroperitoneal fibrosis is widely accepted. The usefulness of this technique in determining the extent of the lesion and for subsequent follow up is underscored.
Moltó Ripoll
F
F
Servicio de Radiodiagnóstico, Hospital General Universitario de Alicante, España.
Merenciano Cortina
F J
FJ
Herraiz Romero
I
I
Vilas Ferrol
I
I
Fernández-Moscoso López-Duran
A
A
Muñoz Nuñez
C
C
Martínez Salinas
P
P
D000328:Adult; D002908:Chronic Disease; D004879:Ergotamines / Q000009:adverse effects*; D006261:Headache / Q000150:complications / Q000188:drug therapy; D006801:Humans; D008297:Male; D012075:Remission, Spontaneous; D012185:Retroperitoneal Fibrosis / Q000139:chemically induced* / Q000175:diagnosis
D004879:Ergotamines